| Probiotic bacteria reduce salmonella typhimurium intestinal colonization by competing for iron E Deriu, JZ Liu, M Pezeshki, RA Edwards, RJ Ochoa, H Contreras, ... Cell host & microbe 14 (1), 26-37, 2013 | 553 | 2013 |
| Heme uptake in bacterial pathogens H Contreras, N Chim, A Credali, CW Goulding Current opinion in chemical biology 19, 34-41, 2014 | 158 | 2014 |
| Three Mycobacterium tuberculosis Rel Toxin-Antitoxin Modules Inhibit Mycobacterial Growth and Are Expressed in Infected Human Macrophages SB Korch, H Contreras, JE Clark-Curtiss Journal of bacteriology 191 (5), 1618-1630, 2009 | 135 | 2009 |
| Characterization of a Mycobacterium tuberculosis nanocompartment and its potential cargo proteins H Contreras, MS Joens, LM McMath, VP Le, MV Tullius, JM Kimmey, ... Journal of Biological Chemistry 289 (26), 18279-18289, 2014 | 114 | 2014 |
| The Mycobacterium tuberculosis secreted protein Rv0203 transfers heme to membrane proteins MmpL3 and MmpL11 CP Owens, N Chim, AB Graves, CA Harmston, A Iniguez, H Contreras, ... Journal of Biological Chemistry 288 (30), 21714-21728, 2013 | 107 | 2013 |
| Development of a multi-antigenic SARS-CoV-2 vaccine candidate using a synthetic poxvirus platform F Chiuppesi, MA Salazar, H Contreras, VH Nguyen, J Martinez, Y Park, ... Nature communications 11 (1), 6121, 2020 | 103 | 2020 |
| The Mycobacterium tuberculosis relBE toxin:antitoxin genes are stress-responsive modules that regulate growth through translation inhibition SB Korch, V Malhotra, H Contreras, JE Clark-Curtiss Journal of Microbiology 53, 783-795, 2015 | 55 | 2015 |
| Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates F Chiuppesi, VH Nguyen, Y Park, H Contreras, V Karpinski, K Faircloth, ... npj Vaccines 7 (1), 7, 2022 | 51 | 2022 |
| A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection DJ Diamond, C La Rosa, F Chiuppesi, H Contreras, S Dadwal, F Wussow, ... Expert review of vaccines 17 (10), 889-911, 2018 | 49 | 2018 |
| Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trial F Chiuppesi, JA Zaia, PH Frankel, R Stan, J Drake, B Williams, AM Acosta, ... The Lancet Microbe 3 (4), e252-e264, 2022 | 46 | 2022 |
| Neutralization of human cytomegalovirus entry into fibroblasts and epithelial cells F Wussow, F Chiuppesi, H Contreras, DJ Diamond Vaccines 5 (4), 39, 2017 | 38 | 2017 |
| Multiantigenic modified vaccinia virus ankara vaccine vectors to elicit potent humoral and cellular immune reponses against human cytomegalovirus in mice F Chiuppesi, J Nguyen, S Park, H Contreras, M Kha, Z Meng, T Kaltcheva, ... Journal of virology 92 (19), 10.1128/jvi. 01012-18, 2018 | 35 | 2018 |
| 20 2 SL Hernández, RML Osorio, LR Orellana, M Martínez, FMA Pérez, ... Manejo y Conservación de las Especies con Valor Comercial de Pata de …, 2010 | 18 | 2010 |
| Comparison of homologous and heterologous prime-boost vaccine approaches using Modified Vaccinia Ankara and soluble protein to induce neutralizing antibodies by the human … F Chiuppesi, F Wussow, L Scharf, H Contreras, H Gao, Z Meng, J Nguyen, ... PLoS One 12 (8), e0183377, 2017 | 13 | 2017 |
| Development of a synthetic poxvirus-based SARS-CoV-2 vaccine F Chiuppesi, MA Salazar, H Contreras, VH Nguyen, J Martinez, S Park, ... BioRxiv, 2020 | 11 | 2020 |
| MVA-vectored pentameric complex (PC) and gB vaccines improve pregnancy outcome after guinea pig CMV challenge, but only gB vaccine reduces vertical transmission H Contreras, F Wussow, C Fernández-Alarcón, C Bierle, J Nguyen, ... Vaccines 7 (4), 182, 2019 | 11 | 2019 |
| The structural characterization of bacterioferritin, BfrA, from Mycobacterium tuberculosis LM McMath, H Contreras, CP Owens, CW Goulding Journal of Porphyrins and Phthalocyanines 17 (03), 229-239, 2013 | 11 | 2013 |
| Factores económicos que impactan los sistemas bovinos de doble propósito y lechería tropical de Veracruz, México JA Espinosa, BA Aguilar, PH Román, HA Contreras, JL Martínez, ... Avances en la Investigación Agrícola, Pecuaria, Forestal y Acuícola en el …, 2007 | 11 | 2007 |
| Advances in Mycobacterium tuberculosis therapeutics discovery utlizing structural biology N Chim, CP Owens, H Contreras, CW Goulding Infectious disorders drug targets, 2012 | 4 | 2012 |
| Synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates. NPJ Vaccines 7: 7 F Chiuppesi, VH Nguyen, Y Park, H Contreras, V Karpinski, K Faircloth, ... | 2 | 2022 |
